Recombinant human erythropoietin(rhEPO)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03835507 (ClinicalTrials.gov)	June 20, 2016	8/8/2018	Randomized, Double-blind, Safety and Efficacy of Recombinant HumanErythropoietin in Amyotrophic Late ...	Randomized, Double-blind, Safety and Efficacy of Recombinant HumanErythropoietin in Amyotrophic Late ...	Amyotrophic Lateral Sclerosis	Drug: recombinant human erythropoietin(rhEPO)	Hanyang University Seoul Hospital	NULL	Recruiting	25 Years	80 Years	All	64	Phase 1/Phase 2	Korea, Republic of

First Previous1Next Last